Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Beta Bionics (BBNX) Accumulated Depreciation & Amortization (2023 - 2026)

Beta Bionics' Accumulated Depreciation & Amortization history spans 4 years, with the latest figure at $6.3 million for Q1 2026.

  • On a quarterly basis, Accumulated Depreciation & Amortization rose 14.11% to $6.3 million in Q1 2026 year-over-year; TTM through Mar 2026 was $6.3 million, a 14.11% increase, with the full-year FY2025 number at $5.8 million, up 9.56% from a year prior.
  • Accumulated Depreciation & Amortization hit $6.3 million in Q1 2026 for Beta Bionics, up from $5.8 million in the prior quarter.
  • Over the last five years, Accumulated Depreciation & Amortization for BBNX hit a ceiling of $6.3 million in Q1 2026 and a floor of $4.4 million in Q4 2023.
  • Historically, Accumulated Depreciation & Amortization has averaged $5.6 million across 4 years, with a median of $5.8 million in 2025.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: increased 18.85% in 2024 and later grew 9.56% in 2025.
  • Tracing BBNX's Accumulated Depreciation & Amortization over 4 years: stood at $4.4 million in 2023, then increased by 18.85% to $5.3 million in 2024, then grew by 9.56% to $5.8 million in 2025, then grew by 10.17% to $6.3 million in 2026.
  • Business Quant data shows Accumulated Depreciation & Amortization for BBNX at $6.3 million in Q1 2026, $5.8 million in Q4 2025, and $6.3 million in Q3 2025.